Novartis offers $470m to boost personalised cancer treatment
January 24, 2011Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine
Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …
Contract research news in brief
January 24, 2011Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody
PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …
OgilvyHealthPR appoints Wendy Gerber and Tania Kouprach-Rolandi
January 24, 2011Medical Communications OgilvyHealthPR, Tania Kouprach-Rolandi, Wendy Gerber, appointment, medical communications
OgilvyHealthPR has strengthened its London team with the appointments of Wendy Gerber and Tania Kouprach-Rolandi, who will focus on HIV, …
Ian Dickety and Sidrah Qureshi join ScopeMedical
January 21, 2011Medical Communications Ian Dickety, ScopeMedical, Sidrah Qureshi, appointments, medical communications
Kent-based med comms agency ScopeMedical has made two new appointments to its team.Starting at the agency are junior digital developer …
Boehringer’s Pradaxa advertising breaches Code
January 21, 2011Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis
Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …
Amgen plant will boost Boehringer Ingelheim’s US presence
January 21, 2011Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing
Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …
ABPI warns of postcode prescribing
January 21, 2011Sales and Marketing ABPI, Cancer Drugs Fund, NICE, cancer drug prescribing, postcode prescribing
The ABPI has said the government’s forthcoming Cancer Drugs Fund could increase the problems of postcode prescribing. The UK industry …
Double Helix expands market research division
January 21, 2011Medical Communications Arijit Ray, Aude Mircovich, Double Helix, Munna Vio, appointment, medical communications
Double Helix has appointed Munna Vio, Arijit Ray and Aude Mircovich (pictured) to its London-based global market research team. Munna …
Pharma manufacturing news in brief
January 21, 2011Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp
Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …
Anne-Marie Rodriguez de Killeen to lead CCA
January 20, 2011Medical Communications Anne-Marie Rodriguez de Killeen, CCA, CCC, Chandler Chicco, appointment, medical communications
Chandler Chicco Companies Europe has promoted Anne-Marie Rodriguez de Killeento managing director for Chandler Chicco Agency. In addition to leading …
Penn Pharma appoints Wyeth’s Edward Rowland
January 20, 2011Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development
Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …
Health Bill continues fast pace of NHS reform
January 20, 2011Sales and Marketing GP consortia, NHS, NHS Commissioning Board, NHS reforms, NICE, QALY
The government has outlined its draft Health and Social Care Bill, making some minor concessions to critics but promising no …
Astellas breaks ground on $95m antibody facility
January 20, 2011Manufacturing and Production Agensys, Astellas, antibodies, antibody
Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …
Caution raised on statins in healthy people
January 20, 2011Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing
Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …
Ex head of European Medicines Agency (EMA) teams up with NDA
January 20, 2011With new drug development costs soaring the NDA Group launches a new regulatory and market access business that aims to …
Key drug launches for 2011
January 20, 2011Sales and Marketing Benlysta, Cladribine, Movectro, Pradaxa, Xarelto, axitinib, boceprevir, crizotinib, telaprevir
This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …
Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG
January 19, 2011Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing
The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …
Trial success for Roche’s personalised skin cancer drug
January 19, 2011Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer
A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …
EMA’s Thomas Lönngren joins market access firm
January 19, 2011Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing
The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …
Sanofi ‘considering’ raising Genzyme offer
January 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions
Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
